Home Cart Sign in  
Chemical Structure| 1939-27-1 Chemical Structure| 1939-27-1

Structure of 1939-27-1

Chemical Structure| 1939-27-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1939-27-1 ]

CAS No. :1939-27-1
Formula : C11H12F3NO
M.W : 231.21
SMILES Code : CC(C)C(NC1=CC=CC(C(F)(F)F)=C1)=O
MDL No. :MFCD00043455
InChI Key :GETMKVRSDFVVHL-UHFFFAOYSA-N
Pubchem ID :137264

Safety of [ 1939-27-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317-H319
Precautionary Statements:P280-P305+P351+P338

Computational Chemistry of [ 1939-27-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 16
Num. arom. heavy atoms 6
Fraction Csp3 0.36
Num. rotatable bonds 4
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 55.37
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

29.1 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.34
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

3.6
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

4.26
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

3.12
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.99
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

3.26

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.56
Solubility 0.0644 mg/ml ; 0.000279 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.9
Solubility 0.0292 mg/ml ; 0.000126 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-4.11
Solubility 0.0178 mg/ml ; 0.0000769 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Moderately soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.15 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<2.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.44

Application In Synthesis of [ 1939-27-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1939-27-1 ]

[ 1939-27-1 ] Synthesis Path-Downstream   1~10

  • 2
  • [ 1939-27-1 ]
  • [ 13311-84-7 ]
YieldReaction ConditionsOperation in experiment
83.3% With sulfuric acid; nitric acid; at -5℃; for 3h; Step 3, put a 100ml three-necked bottle with mechanical stirring and thermometer into the ice machine, add 23ml of concentrated sulfuric acid, stir,Addition of 10.75g of iso - butyramide benzotrifluoride until the solid dissolves, keeping the temperature at -5 C, adding 2.3ml of 95% fuming HN03, stirring 3h; Step 4, the above reaction was poured into a certain amount of ice water mixture, was sticky solid, add 80g toluene, stirring,Separation, the upper organic phase was washed three times with 3% sodium bicarbonate solution, followed by three washes, and the solvent was removed by rotary evaporation to give a yellow solid; Step 5, the above yellow solid was added to the flask, 20 ml of ethanol was added, and the mixture was heated to reflux, solid 1% of activated carbon was added, stirred for 5 minutes, and hot filtered.The filtrate was cooled to room temperature, and petroleum ether was slowly added thereto until the solution became turbid. The solution was refrigerated at 0C for 3 hours, filtered, and dried at 60C to obtain flunitamide as a pale yellow solid.
69% With 3-(ethoxycarbonyl)-1-(5-methyl-5-(nitrosooxy)hexyl)pyridin-1-ium bis(trifluoromethanesulfonyl)imide; at 20℃; for 5h;Ionic liquid; General procedure: To a Schlenk tube were added arene (1 mmol) and TS-N-IL (1.3 mmol). Then the tube was stirred at room temperature under air for the indicated time until complete consumption of starting material as monitored by TLC analysis. After the reaction was finished, the reaction mixture was extracted with ethyl acetate (3 20 mL). The combined extracts were washed with aqueous NaHCO3, dried over anhydrous Na2SO4 and evaporated in a rotary evaporator under reduced pressure. The crude product was purified by filtration through a column chromatography on silica gel employing ethyl acetate-hexane mixture to afford the desired product. The purity of the compound was confirmed by NMR and mass analysis, vide infra.
With nitric acid; EXAMPLE 1 3'-Trifluoromethyl-4'-Nitro-Isobutyranilide Add portion-wise 57.5 g. of m-trifluoromethyl isobutyranilide to 260 ml. of 15-18% oleum while maintaining the internal temperature at about 5 C. To this mixture add drop-wise 20 g. of 90% nitric acid with stirring. Stir at about 5 C. for 2 hours and pour into about 11/2 liters of ice and water with stirring. Collect the 3'-trifluoromethyl-4'-nitro-isobutyranilide by filtration and wash with water until substantially free of excess acid.
41 g With sulfuric acid; nitric acid; at 0 - 5℃; for 3h; Flutamide was synthesised and purified by modification of a literature procedure.4 3-Trifluoromethylisobutyranilide (58 g, 0.25 mol) was dissolved in concentrated sulfuric acid (200 mL, 2.2 mol) at 0-5 C with efficient agitation (CAUTION: strong acid). A pre-cooled mixture of 98% sulfuric acid (20 mL, 0.22 mol) and 65% nitric acid (20 mL, 0.29 mol) (CAUTION: strong acids) was added dropwise to the above solution while the temperature was controlled at 0-5 C. Stirring was continued for 3 h, and the mixture was poured onto crushed ice (500 g) mixed efficiently with a mechanical stirrer in a 2 L beaker. The crude product was filtered under suction. The precipitate obtained was dissolved in 96% ethanol (350 mL) under reflux and decolourised with charcoal (10 g) by 15 minutes heating and filtered. The filtrate was cooled and precipitated with drop-wise addition of distilled water (1.5 L). After 60 min in an ice-cooled bath the yellow precipitate was filtered off and dried in a good ventilating hood. The impure product (50 g, 0.18 mol) was twice re-crystallised from toluene (150 mL) for further purification. The pale yellow needles haped crystals (41 g, 0.15 mol) of flutamide were obtained after gentle drying under reduced pressure (60% based on the starting material, 3-trifluoroisobutyranilde). The overall yield of three steps was 45% based on benzotrifluoride. M.p. 111.5-112 C (lit.4,1 111.5-112 C and110-111 C). IR(KBr) nu = 3360 (N-H, stretching), 3100-3000 (C-Haromatic), 1717 (C=O), 1543 (N-H, bending), 1517 and 1347 (N-O),1243 (C-F). 1H NMR (80 MHz, DMSO-d6) delta = 1.02 (d, 6H, (CH3)2), 2.57(m, 1H, CH(CH3)2), 7.75 (d, 2H, ArH), 8.20 (s, 1H, ArH), 10.27 (bs, 1H,N-H).

  • 3
  • [ 98-16-8 ]
  • [ 79-31-2 ]
  • [ 1939-27-1 ]
  • 4
  • [ 98-08-8 ]
  • [ 1939-27-1 ]
  • 5
  • [ 98-46-4 ]
  • [ 79-31-2 ]
  • [ 1939-27-1 ]
YieldReaction ConditionsOperation in experiment
95% With sodium sulfite; for 16h;Reflux; General procedure: A mixture of aromatic nitro compound (10 mmol), sodium sulfite (35 mmol) and carboxylic acid (80 mmol) wasrefluxed for 16 hours. The reaction mixture was poured to a mixture of ethyl acetate (50 mL) and water (50 mL). Organicphase was separated, dried on sodium sulfate and evaporated to produce crude product. The product was purified bycolumn chromatography or by re-crystallization in the mixture of methanol : water (1:1). Furthermore, it is important tonote that this methodology is scaled-up to kilogram scale without any difficulty. For this obJective, the acetaminophen andpropanil was prepared in 10 mole scale with technical grade 4-nitrophenol and 3,4-dichloronitrobenzene, acetic acid andpropionic acid respectively.
81% With iron; for 4h;Reflux; Inert atmosphere; Iron powder (60 g, 1.07 mol) was added gradually to a mixture of 1-nitro-3-trifluoromethyl benzene (63.5 g, 0.33 mol) and isobutyric acid (220 mL, 2.42 mol) under reflux conditions in a nitrogen atmosphere was added over about 15 min. Heating and mixing was continued for 4 h, and then the mixture was poured into a mixture of concentrated hydrochloric acid (200 mL) and crushed ice (500 g) and agitated for 15 minutes. The reaction mixture was extracted with ethyl acetate (2 × 500 mL). After evaporating to dryness, the crude product was dissolved in methanol (1000 mL) and after adding charcoal (10 g), the mixture was boiled for 10 minutes and filtered while it was hot. Water (2500 mL) was added to the solution obtained with stirring and cooling to 0-5 C. The mixture was kept at 0-5 C for 2 h. Flaky cream crystals were obtained. 3-Trifluoromethylisobutyranilide (62 g, 0.268 mol) was filtered under suction (81% based on the starting material). M.p. 117-118 C (lit.4 115-120 C). IR(KBr) nu = 663, 892,1069, 1107, 1252, 1275, 1388, 1165, 2979, 3253. 1H NMR (80 MHz, DMSO-d6) delta = 1.05 (d, 6H, (CH3)2), delta 2.48 (m, 1H, CH), delta 7.31 (m, 2H,ArH), delta 7.72 (d, 1H, ArH), delta 7.95 (m, 1H, ArH), delta 8.08 (s, 1H, ArH),10.10 (bs, 1H, NH).
  • 6
  • [ 13311-84-7 ]
  • [ 67-63-0 ]
  • [ 76-09-5 ]
  • [ 1939-27-1 ]
YieldReaction ConditionsOperation in experiment
Irradiation; High pressure; General procedure: Flutamide and product 4 were irradiated with UV produced using a super-high pressure mercury lamp (500W, Ushio Inc.) and filtered through UV-29 (Toshiba) and cylindrical cell filter filled with distilled water to remove infrared light. Irradiation experiments using deuterated solvents were conducted using the same apparatus.
  • 7
  • [ 13311-84-7 ]
  • [ 67-63-0 ]
  • [ 1939-27-1 ]
  • 1-methylethyl 2-amino-5-(2-methylpropanamido)benzoate [ No CAS ]
  • [ 39235-51-3 ]
  • 2-methyl-N-[4-hydroxy-3-(trifluoromethyl)phenyl]propanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With oxygen;Irradiation; High pressure; General procedure: Flutamide and product 4 were irradiated with UV produced using a super-high pressure mercury lamp (500W, Ushio Inc.) and filtered through UV-29 (Toshiba) and cylindrical cell filter filled with distilled water to remove infrared light. Irradiation experiments using deuterated solvents were conducted using the same apparatus.
  • 8
  • [ 13311-84-7 ]
  • [ 1939-27-1 ]
  • [ 39235-51-3 ]
  • 2-methyl-N-[4-hydroxy-3-(trifluoromethyl)phenyl]propanamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
With oxygen; In acetonitrile;Irradiation; High pressure; General procedure: Flutamide and product 4 were irradiated with UV produced using a super-high pressure mercury lamp (500W, Ushio Inc.) and filtered through UV-29 (Toshiba) and cylindrical cell filter filled with distilled water to remove infrared light. Irradiation experiments using deuterated solvents were conducted using the same apparatus.
  • 9
  • [ 563-83-7 ]
  • [ 401-81-0 ]
  • [ 1939-27-1 ]
YieldReaction ConditionsOperation in experiment
60% With cobalt(II) oxalate dihydrate; caesium carbonate; N,N`-dimethylethylenediamine; In water; at 130℃; for 24h;Green chemistry; General procedure: A mixture of cobalt(II) oxalate dihydrate(Sigma-Aldrich, 0.294 mmol), Cs2CO3 (2.94 mmol), pyrrolidinoneor aliphatic amide (1.47 mmol), DMEDA (0.588 mmol),distilled H2O (0.3 mL) and aryl halide (2.205 mmol) were addedto an 8.0-mL reaction vial fitted with a Teflon-sealed screw cap.The reaction mixture was stirred under air in a closed system at120 C and 130 C, respectively for 24 h. The heterogeneousmixture was subsequently cooled to r.t. and diluted withCH2Cl2. The combined organic extracts were dried over anhydNa2SO4, filtered and the solvent was removed under reducedpressure. The crude product was loaded into the column usingminimal amounts of CH2Cl2 and was purified by silica gel column chromatography to afford the N-arylated product. Theidentity and purity of products were confirmed by 1H NMR and13C NMR spectroscopic analysis.
  • 10
  • [ 97-72-3 ]
  • [ 98-16-8 ]
  • [ 1939-27-1 ]
YieldReaction ConditionsOperation in experiment
Step 1. After adding 20 ml of n-hexane to a 100 ml three-necked flask, add 2.0 g of catalyst and 3.22 g of m-trifluoromethylaniline.The magnetic stirrer was turned on, heated to 45 C, and 6.32 g of isobutyric anhydride was added dropwise within 30 min, and incubated for 1 h. Sample analysis was performed.Step 2. Add 10 ml of water to the reaction solution. After the addition, the temperature is lowered. Add 10 ml of 30% NaOH solution again. The temperature rises above 50C.Warming to 70 C, heat 15min, placed in an ice machine, cooled to 10 C, filtered, vacuum dried at 60 C, a white solid;
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 1939-27-1 ]

Fluorinated Building Blocks

Chemical Structure| 25617-34-9

A434785 [25617-34-9]

N-(4-(Trifluoromethyl)phenyl)pivalamide

Similarity: 1.00

Chemical Structure| 24522-30-3

A223623 [24522-30-3]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.88

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.83

Chemical Structure| 25625-57-4

A135677 [25625-57-4]

2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 3823-19-6

A893639 [3823-19-6]

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Aryls

Chemical Structure| 25617-34-9

A434785 [25617-34-9]

N-(4-(Trifluoromethyl)phenyl)pivalamide

Similarity: 1.00

Chemical Structure| 24522-30-3

A223623 [24522-30-3]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.88

Chemical Structure| 25625-57-4

A135677 [25625-57-4]

2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 3823-19-6

A893639 [3823-19-6]

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 90357-53-2

A305606 [90357-53-2]

N-(4-Cyano-3-(trifluoromethyl)phenyl)methacrylamide

Similarity: 0.78

Amides

Chemical Structure| 25617-34-9

A434785 [25617-34-9]

N-(4-(Trifluoromethyl)phenyl)pivalamide

Similarity: 1.00

Chemical Structure| 24522-30-3

A223623 [24522-30-3]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.88

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.83

Chemical Structure| 25625-57-4

A135677 [25625-57-4]

2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 3823-19-6

A893639 [3823-19-6]

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Amines

Chemical Structure| 25617-34-9

A434785 [25617-34-9]

N-(4-(Trifluoromethyl)phenyl)pivalamide

Similarity: 1.00

Chemical Structure| 24522-30-3

A223623 [24522-30-3]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.88

Chemical Structure| 25625-57-4

A135677 [25625-57-4]

2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 3823-19-6

A893639 [3823-19-6]

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 90357-53-2

A305606 [90357-53-2]

N-(4-Cyano-3-(trifluoromethyl)phenyl)methacrylamide

Similarity: 0.78

Trifluoromethyls

Chemical Structure| 25617-34-9

A434785 [25617-34-9]

N-(4-(Trifluoromethyl)phenyl)pivalamide

Similarity: 1.00

Chemical Structure| 24522-30-3

A223623 [24522-30-3]

2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.88

Chemical Structure| 22123-19-9

A122580 [22123-19-9]

6-Methyl-4-(trifluoromethyl)pyridin-2(1H)-one

Similarity: 0.83

Chemical Structure| 25625-57-4

A135677 [25625-57-4]

2-Bromo-N-(3-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82

Chemical Structure| 3823-19-6

A893639 [3823-19-6]

2-Bromo-N-(4-(trifluoromethyl)phenyl)acetamide

Similarity: 0.82